| Tag | Content |
|---|
EnhancerAtlas ID | HS034-16149 |
Organism | Homo sapiens |
Tissue/cell | ECC-1 |
Coordinate | chr2:28940090-28940930 |
SNPs | | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| NFAT5 | MA0606.1 | chr2:28940106-28940116 | ATTTTCCATT | + | 6.02 | | NFATC1 | MA0624.1 | chr2:28940106-28940116 | ATTTTCCATT | + | 6.02 | | NFATC3 | MA0625.1 | chr2:28940106-28940116 | ATTTTCCATT | + | 6.02 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_02169 | chr2:28939958-28940678 | Aorta | | SE_41111 | chr2:28938705-28940799 | Left_Ventricle |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I028713 | chr2 | 28936139 | 28941575 |
|
Enhancer Sequence | AATCACAGCA GAAAGCATTT TCCATTTCAG GGAAAGGAGA GAACAGGCCA TAAACCCTGT 60
CCCCTGTTTG TTCTCCAACT ACCCATTTTT GTCCTTTGCC CTGCCATGTC TTTTCCCCCT 120
CGTTTGCTTC TCCTTTCTTT GTTGATTTCT CAGTTCTTTT CTGGCCTCAC TCAAAATGGC 180
AGAAATTACG CAACCTAGTA CTTTTTTACA CAAGCTCCTT TAGTGTCAAG GATTCATCAA 240
GTGCCTGCCA TGTGCCGGAA CTGTTCTAGA TGCCGAGAAT ACTACCATGA ATGAAATAGA 300
CAGAAATCCC GGCTGTCATT GGGCTTTGTC TGAGGGCCAT TGGGGAAGGC CTCTCAAAGG 360
AAGTGATAGC TGAGCTGGGA TCTGAGTCAT GAAGAGGAGT GAGCCCAGGG GACAACAGCT 420
GCAAGAGTGT GCCAATGGGA GAGACCAGCC CAGCAAAAAG GAGAAGCATA AGTCTGGTGC 480
ATTCCAGGGA CAGGAAGGAA TGGGGCAGGG TGCCTTTAAG AGAAAAGCAT CAGTTTGGAT 540
GAGGAGGGAT GTAGGGTCGG GAATACAAAA TAAGAGTAAT TATGGCTGGG CACAATAGCT 600
CACACCTGTA ATCCCAGGAC TTTGGGAGGC CAAGGTGGGC GGATCACTTG AGGTCGGGAG 660
TTAGAGACCA GCCTGGCCAA CATGGCGAAA CCCTGTCTCT ACCAAAAATA CAAAAATTAG 720
CTAGGCCTGG TGGTACGTGC CTGTAATCCC AGCTACTCGG GAGACTGAGG CAGGAGGCAG 780
AGGTTGCAGT AAACCAAGAT CGCGCCACTG CACTCCAGCC TGGGCAAAAG AGTGAAAGTG 840
|
